{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:41:02Z","timestamp":1792683662647,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Noncommunicable Chronic Diseases\u2013National Science and Technology","award":["2024ZD0532800"],"award-info":[{"award-number":["2024ZD0532800"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Aspergillus galactomannan chemiluminescence immunoassay (GM\u2013CLIA) is a novel non-culture-based test applied in the detection of GM antigen in serum and bronchoalveolar lavage fluid (BALF). This multicenter, retrospective, and controlled study aims to investigate its diagnostic value for invasive aspergillosis (IA). A total of 246 serum and 228 BALF samples were obtained from IA patients (n\u00a0=\u00a0229) and non-IA (n\u00a0=\u00a0236) patients between March 2023 and July 2024. The performance of GM-CLIA was compared with that of Aspergillus GM sandwich enzyme immunoassay (GM-EIA) through Spearman rank correlation analysis and assessed via sensitivity, specificity, positive\/negative predictive values (PPV\/NPV), and receiver operating characteristic (ROC) curve analysis. Analytical performance was evaluated through interference, precision, limit of detection (LoD), and cross-reactivity experiments. The sensitivity, specificity, PPV, and NPV of serum GM\u2013CLIA were 93.97%, 97.46%, 97.32%, and 94.26%, respectively. For BALF GM\u2013CLIA, the corresponding values were 93.58%, 95.76%, 95.33%, and 94.17%. ROC analysis yielded high area under the curve (serum: 0.977; BALF: 0.982) with optimal cut-offs of 0.625 (serum) and 0.615 (BALF). The levels of GM by CLIA and EIA (rs\u00a0=\u00a00.838, P &amp;lt; 0.0001) strongly correlated. No interference was observed from hemoglobin, bilirubin, or triglycerides at certain concentrations. Repeatability, indoor, and inter-batch precision met predefined criteria, with no cross-reactivity in non-Aspergillus pathogens. The LoD for detecting GM\u2013CLIA was 0.09 ng\/ml. In summary, GM\u2013CLIA was evaluated in both sample types, demonstrating high specificity and sensitivity in diagnosing IA. Thus, clinical implementation of CLIA may significantly improve diagnostic efficiency and patient outcomes.<\/jats:p>","DOI":"10.1093\/mmy\/myag062","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:19:26Z","timestamp":1792408766000},"source":"Crossref","is-referenced-by-count":0,"title":["A novel\n                    <i>Aspergillus<\/i>\n                    galactomannan chemiluminescence immunoassay: Evaluation for diagnosis of invasive pulmonary aspergillosis in a multicenter controlled study"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-8541","authenticated-orcid":false,"given":"Yuling","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiji","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao\u2013Yang Hospital, Capital Medical University , Beijing 100020 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao\u2013Yang Hospital, Capital Medical University , Beijing 100020 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao\u2013Yang Hospital, Capital Medical University , Beijing 100020 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Health Management Center, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibo","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University , Kunming 650032 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University , Kunming 650032 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Xi\u2019an Jiaotong University , Xi\u2019an 710003 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Xi\u2019an Jiaotong University , Xi\u2019an 710003 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine , Chengdu 610041 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"6","key":"2026102210535580700_bib1","doi-asserted-by":"publisher","first-page":"FSO307","DOI":"10.4155\/fsoa-2018-0019","article-title":"Invasive fungal infections in high-risk patients: Report from TIMM-8 2017","volume":"4","author":"Pagano","year":"2018","journal-title":"Future Sci OA"},{"issue":"7","key":"2026102210535580700_bib2","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2026102210535580700_bib3","doi-asserted-by":"publisher","first-page":"e1011322","DOI":"10.1371\/journal.ppat.1011322","article-title":"Advances in the treatment of invasive fungal disease","volume":"19","author":"Zhang","year":"2023","journal-title":"PLoS Pathog"},{"key":"2026102210535580700_bib4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/B978-0-7020-4088-7.00095-X","article-title":"Fungal infections of the central nervous system","volume":"121","author":"Murthy","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"2026102210535580700_bib5","doi-asserted-by":"publisher","first-page":"e750","DOI":"10.1016\/S2352-3018(23)00174-1","article-title":"HIV and fungal priority pathogens","volume":"10","author":"Sati","year":"2023","journal-title":"Lancet HIV"},{"issue":"1","key":"2026102210535580700_bib6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","article-title":"Diagnosis of invasive fungal infections: challenges and recent developments","volume":"30","author":"Fang","year":"2023","journal-title":"J. Biomed. Sci"},{"issue":"3","key":"2026102210535580700_bib7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"2026102210535580700_bib8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2026102210535580700_bib9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41598-021-03099-w","article-title":"Clinical features of invasive fungal disease in children with no underlying disease","volume":"12","author":"Huang","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"2026102210535580700_bib10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis."},{"issue":"Suppl 1","key":"2026102210535580700_bib11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2026102210535580700_bib12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and treatment of cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2026102210535580700_bib13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis."},{"issue":"2","key":"2026102210535580700_bib14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/antibiotics12020385","article-title":"Current and future pathways in Aspergillus diagnosis","volume":"12","author":"Dobi\u00e1\u0161","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"2026102210535580700_bib15","doi-asserted-by":"publisher","first-page":"115274","DOI":"10.1016\/j.diagmicrobio.2020.115274","article-title":"Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"99","author":"Wu","year":"2021","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"1","key":"2026102210535580700_bib16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","article-title":"Diagnosis of invasive fungal infections: challenges and recent developments","volume":"30","author":"Fang","year":"2023","journal-title":"J Biomed Sci."},{"issue":"3","key":"2026102210535580700_bib17","doi-asserted-by":"publisher","first-page":"e56147","DOI":"10.7759\/cureus.56147","article-title":"Clinicomycological study of the spectrum of pulmonary aspergillosis at a Tertiary Care Hospital in Central India","volume":"16","author":"Krishna","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"2026102210535580700_bib18","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1128\/JCM.00906-15","article-title":"Analytical comparison of In Vitro-Spiked Human Serum and Plasma for PCR-based Detection of Aspergillus fumigatus DNA: a sudy by the European Aspergillus PCR Initiative","volume":"53","author":"Loeffler","year":"2015","journal-title":"J Clin Microbiol."},{"issue":"12","key":"2026102210535580700_bib19","doi-asserted-by":"publisher","first-page":"CD007394","DOI":"10.1002\/14651858.CD007394.pub2","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2017","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"2026102210535580700_bib20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","article-title":"Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis","volume":"4","author":"Mennink-Kersten","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2026102210535580700_bib21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11046-023-00798-y","article-title":"Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological malignancy","volume":"188","author":"Das","year":"2023","journal-title":"Mycopathologia"},{"issue":"3","key":"2026102210535580700_bib22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/jmv.26430","article-title":"Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 patients","volume":"93","author":"Soleimani","year":"2021","journal-title":"J. Med Virol."},{"issue":"2","key":"2026102210535580700_bib23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00705-020-04897-9","article-title":"Chemiluminescent-microparticle-immunoassay-based detection and prevalence of human immunodeficiency virus infection in Islamabad","volume":"166","author":"Din","year":"2021","journal-title":"Pakistan. Arch Virol"},{"issue":"1","key":"2026102210535580700_bib24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.diagmicrobio.2017.12.022","article-title":"A novel chemiluminescent immunoassay based on original acridinium ester labels as better solution for diagnosis of human toxoplasmosis than conventional ELISA test","volume":"91","author":"Holec-G\u0105sior","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"2026102210535580700_bib25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jim-2015-000004","article-title":"Good diagnostic accuracy of a chemiluminescent immunoassay in stool samples for diagnosis of Helicobacter pylori infection in patients with dyspepsia","volume":"64","author":"Ram\u00edrez-L\u00e1zaro","year":"2016","journal-title":"J. Investig. Med."},{"issue":"7","key":"2026102210535580700_bib26","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10096-017-2916-9","article-title":"Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection","volume":"36","author":"Makristathis","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"2","key":"2026102210535580700_bib27","doi-asserted-by":"publisher","first-page":"e0105324","DOI":"10.1128\/jcm.01053-24","article-title":"Multicenter validation of a galactomannan chemiluminescence immunoassay for the diagnosis of pulmonary aspergillosis on serum of patients with hematological disease","volume":"63","author":"Lamberink","year":"2025","journal-title":"J Clin Microbiol."},{"issue":"5","key":"2026102210535580700_bib28","doi-asserted-by":"publisher","first-page":"e0004423","DOI":"10.1128\/jcm.00044-23","article-title":"Retrospective multicenter evaluation of the virclia galactomannan antigen assay for the diagnosis of pulmonary aspergillosis with bronchoalveolar lavage fluid samples from patients with hematological disease","volume":"61","author":"Buil","year":"2023","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"2026102210535580700_bib29","doi-asserted-by":"publisher","first-page":"e0262621","DOI":"10.1128\/spectrum.02626-21","article-title":"Comparison of the performance of two galactomannan detection tests: platelia Aspergillus Ag and Aspergillus Galactomannan Ag virclia monotest","volume":"10","author":"Calero","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026102210535580700_bib30","doi-asserted-by":"publisher","first-page":"123392","DOI":"10.1016\/j.talanta.2022.123392","article-title":"Sandwich-type homogeneous chemiluminescence immunoassay based on nanoparticle toward detection of Aspergillus galactomannan antigen","volume":"243","author":"Guo","year":"2022","journal-title":"Talanta"},{"issue":"3","key":"2026102210535580700_bib31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4067\/s0716-10182022000200248","article-title":"Evaluaci\u00f3n de la prueba Aspergillus Galactomannan Ag VircliaR Monotest como alternativa a kit Platelia\u2122 Aspergillus EIA [Evaluation of the Aspergillus Galactomannan Ag VircliaR Monotest test as an alternative to Platelia\u2122 Aspergillus EIA kit]","volume":"39","author":"Troncoso","year":"2022","journal-title":"Rev Chilena Infectol"},{"issue":"12","key":"2026102210535580700_bib32","doi-asserted-by":"publisher","first-page":"e0095024","DOI":"10.1128\/jcm.00950-24","article-title":"Serum antigen tests for the diagnosis of invasive aspergillosis: a retrospective comparison of five Aspergillus antigen assays and one beta-D-glucan assay","volume":"62","author":"Schub","year":"2024","journal-title":"J Clin Microbiol."},{"issue":"4","key":"2026102210535580700_bib33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med."},{"issue":"Suppl 7","key":"2026102210535580700_bib34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imj.15591","article-title":"Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021","volume":"51","author":"Douglas","year":"2021","journal-title":"Intern Med J"},{"issue":"6","key":"2026102210535580700_bib35","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2026102210535580700_bib36","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/myc.13274","article-title":"Invasive aspergillosis in critically ill patients: review of definitions and diagnostic approaches","volume":"64","author":"Jenks","year":"2021","journal-title":"Mycoses"},{"issue":"7","key":"2026102210535580700_bib37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"2026102210535580700_bib38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/apm.13316","article-title":"Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices","volume":"131","author":"Gaffney","year":"2023","journal-title":"APMIS"},{"key":"2026102210535580700_bib39","doi-asserted-by":"publisher","first-page":"631461","DOI":"10.3389\/fmed.2021.631461","article-title":"The clinical characteristics of patients with nonneutropenic invasive pulmonary aspergillosis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"2026102210535580700_bib40","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/crj.12722","article-title":"Analysis of the clinical features of invasive bronchopulmonary aspergillosis","volume":"12","author":"Cao","year":"2018","journal-title":"Clin Respir J"},{"issue":"6","key":"2026102210535580700_bib41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/antibiotics11060730","article-title":"Combination of C-reactive protein and procalcitonin in distinguishing fungal from bacterial infections early in immunocompromised children","volume":"11","author":"Liu","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"2026102210535580700_bib42","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/INF.0b013e3181e7db7f","article-title":"Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation","volume":"29","author":"Villarroel","year":"2010","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"2026102210535580700_bib43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10096-023-04724-4","article-title":"Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: a multicenter study","volume":"43","author":"Guo","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"2026102210535580700_bib44","doi-asserted-by":"publisher","first-page":"5434589","DOI":"10.1155\/2020\/5434589","article-title":"Diagnostic accuracy of bronchoalveolar lavage fluid galactomannan for invasive aspergillosis","volume":"2020","author":"Cao","year":"2020","journal-title":"Biomed Res Int"},{"issue":"4","key":"2026102210535580700_bib45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1378\/chest.10-0488","article-title":"Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review","volume":"138","author":"Guo","year":"2010","journal-title":"Chest"},{"issue":"6","key":"2026102210535580700_bib46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","article-title":"Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis","volume":"4","author":"Mennink-Kersten","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2026102210535580700_bib47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","article-title":"Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test","volume":"46","author":"Eigl","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"2026102210535580700_bib48","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis."},{"issue":"14","key":"2026102210535580700_bib49","doi-asserted-by":"publisher","first-page":"e25233","DOI":"10.1097\/MD.0000000000025233","article-title":"Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannan, and serum 1,3-\u03b2-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis","volume":"100","author":"Dai","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2026102210535580700_bib50","doi-asserted-by":"publisher","first-page":"e0021522","DOI":"10.1128\/jcm.00215-2","article-title":"Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid","volume":"60","author":"Egger","year":"2022","journal-title":"J Clin Microbiol."}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myag062\/72256827\/myag062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/64\/10\/myag062\/72256827\/myag062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/64\/10\/myag062\/72256827\/myag062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:54:04Z","timestamp":1792680844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myag062\/8965142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,2]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myag062","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10]]},"article-number":"myag062"}}